Kala Pharmaceuticals, Inc. (KALA)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
17-Nov-21 8:01 PM
View: 
Blumenkranz Mark S.
Director
Kala Pharmaceuticals, Inc. (KALA) 15-Nov-21Grant 157,765----100%
0 to 157.76K
17-Nov-21 8:01 PM
View: 
Blumenkranz Mark S.
Director
Kala Pharmaceuticals, Inc. (KALA) 15-Nov-21Grant 5,183,360----3285%
157.76K to 5.34M
17-Nov-21 8:02 PM
View: 
Kharabi Darius
CHIEF BUSINESS OFFICER
Kala Pharmaceuticals, Inc. (KALA) 15-Nov-21Grant 295,657----100%
0 to 295.66K
28-Oct-21 8:06 PM
View: 
Chen Hongming
Chief Scientific Officer
Kala Pharmaceuticals, Inc. (KALA) 27-Oct-21Market Sale (Planned) 21,051$1.82$38,312.80(9%)
225.57K to 204.51K
4%
28-Oct-21 8:04 PM
View: 
Reumuth Mary
Chief Financial Officer
Kala Pharmaceuticals, Inc. (KALA) 26-Oct-21Market Sale (Planned) 9,449$1.80$17,008.20(6%)
145.51K to 136.06K
3%
28-Oct-21 8:03 PM
View: 
Bazemore Todd
Chief Operating Officer
Kala Pharmaceuticals, Inc. (KALA) 26-Oct-21Market Sale (Planned) 12,544$1.80$22,579.20(9%)
134.63K to 122.09K
3%
28-Oct-21 8:06 PM
View: 
Chen Hongming
Chief Scientific Officer
Kala Pharmaceuticals, Inc. (KALA) 26-Oct-21Market Sale (Planned) 9,449$1.80$17,008.20(4%)
235.01K to 225.57K
3%
28-Oct-21 8:01 PM
View: 
Iwicki Mark T
Chief Executive Officer
Director
Kala Pharmaceuticals, Inc. (KALA) 26-Oct-21Market Sale (Planned) 27,598$1.80$49,676.40(9%)
296.27K to 268.68K
3%
28-Oct-21 8:05 PM
View: 
Trachtenberg Eric
See Remarks
Kala Pharmaceuticals, Inc. (KALA) 26-Oct-21Market Sale (Planned) 9,449$1.80$17,008.20(7%)
126.11K to 116.67K
3%
28-Oct-21 8:02 PM
View: 
Brazzell Kim
Chief Medical Officer
Kala Pharmaceuticals, Inc. (KALA) 26-Oct-21Market Sale (Planned) 12,757$1.80$22,962.60(4%)
304.61K to 291.85K
3%
30-Jun-21 5:30 PM
View: 
Chen Hongming
Chief Scientific Officer
Kala Pharmaceuticals, Inc. (KALA) 29-Jun-21Market Sale (Planned) 5,548$5.56$30,846.90(2%)
240.56K to 235.01K
2%
29-Jun-21 5:26 PM
View: 
Chen Hongming
Chief Scientific Officer
Kala Pharmaceuticals, Inc. (KALA) 28-Jun-21Market Sale (Planned) 2,452$5.77$14,148.00(1%)
243.01K to 240.56K
4%
29-Jun-21 5:25 PM
View: 
Bazemore Todd
Chief Operating Officer
Kala Pharmaceuticals, Inc. (KALA) 28-Jun-21Market Sale (Planned) 2,911$5.77$16,796.50(99%)
2.95K to 42
4%
29-Jun-21 5:25 PM
View: 
Iwicki Mark T
Chief Executive Officer
Director
Kala Pharmaceuticals, Inc. (KALA) 28-Jun-21Market Sale (Planned) 7,586$5.77$43,771.20(2%)
303.86K to 296.27K
4%
29-Jun-21 5:26 PM
View: 
Trachtenberg Eric
See Remarks
Kala Pharmaceuticals, Inc. (KALA) 28-Jun-21Market Sale (Planned) 2,452$5.77$14,148.00(2%)
128.57K to 126.11K
4%
29-Jun-21 5:26 PM
View: 
Brazzell Kim
Chief Medical Officer
Kala Pharmaceuticals, Inc. (KALA) 28-Jun-21Market Sale (Planned) 3,034$5.77$17,506.20(< 1%)
304.0K to 300.96K
4%
29-Jun-21 5:26 PM
View: 
Reumuth Mary
Chief Financial Officer
Kala Pharmaceuticals, Inc. (KALA) 28-Jun-21Market Sale (Planned) 2,452$5.77$14,148.00(2%)
147.96K to 145.51K
4%
21-Jun-21 5:30 PM
View: 
Grunberg Gregory
Director
Kala Pharmaceuticals, Inc. (KALA) 17-Jun-21Grant 20,000----< 1%
5.43M to 5.45M
21-Jun-21 5:30 PM
View: 
Paull Robert Bradley
Director
Kala Pharmaceuticals, Inc. (KALA) 17-Jun-21Grant 20,000----89%
22.36K to 42.36K
21-Jun-21 5:31 PM
View: 
Rosen Howard B
Director
Kala Pharmaceuticals, Inc. (KALA) 17-Jun-21Grant 20,000----60%
33.06K to 53.06K
21-Jun-21 5:30 PM
View: 
Perry Gregory D
Director
Kala Pharmaceuticals, Inc. (KALA) 17-Jun-21Grant 20,000----100%
20.0K to 40.0K
21-Jun-21 5:30 PM
View: 
Koven Andrew I
Director
Kala Pharmaceuticals, Inc. (KALA) 17-Jun-21Grant 25,000----89%
28.0K to 53.0K
21-Jun-21 5:31 PM
View: 
Shah Rajeev M.
Director
Kala Pharmaceuticals, Inc. (KALA) 17-Jun-21Grant 20,000----< 1%
10.89M to 10.91M
05-Apr-21 4:31 PM
View: 
Ra Capital Management, LLC
Director
10% Owner
Kala Pharmaceuticals, Inc. (KALA) 01-Apr-21Acquisition (other) 1,687,710$6.74$11,375,200.0018%
9.19M to 10.87M
03-Mar-21 5:01 PM
View: 
Chen Hongming
Chief Scientific Officer
Kala Pharmaceuticals, Inc. (KALA) 01-Mar-21Option Exercise 9,500$2.30$21,850.004%
233.51K to 243.01K
26-Feb-21 5:35 PM
View: 
Chen Hongming
Chief Scientific Officer
Kala Pharmaceuticals, Inc. (KALA) 25-Feb-21Option Exercise 47,000$2.30$108,100.0025%
186.51K to 233.51K
05-Jan-21 4:50 PM
View: 
Iwicki Mark T
Chief Executive Officer
Director
Kala Pharmaceuticals, Inc. (KALA) 04-Jan-21Grant 76,000----33%
227.86K to 303.86K
05-Jan-21 4:55 PM
View: 
Trachtenberg Eric
See Remarks
Kala Pharmaceuticals, Inc. (KALA) 04-Jan-21Grant 22,666----21%
105.9K to 128.57K
05-Jan-21 4:59 PM
View: 
Brazzell Kim
Chief Medical Officer
Kala Pharmaceuticals, Inc. (KALA) 04-Jan-21Grant 27,500----10%
276.5K to 304.0K
05-Jan-21 4:48 PM
View: 
Reumuth Mary
Chief Financial Officer
Kala Pharmaceuticals, Inc. (KALA) 04-Jan-21Grant 22,666----18%
125.29K to 147.96K
05-Jan-21 4:53 PM
View: 
Bazemore Todd
Chief Operating Officer
Kala Pharmaceuticals, Inc. (KALA) 04-Jan-21Grant 27,500----25%
110.04K to 137.54K
05-Jan-21 4:57 PM
View: 
Chen Hongming
Chief Scientific Officer
Kala Pharmaceuticals, Inc. (KALA) 04-Jan-21Grant 22,666----14%
163.85K to 186.51K
28-Oct-20 8:30 PM
View: 
Chen Hongming
Chief Scientific Officer
Kala Pharmaceuticals, Inc. (KALA) 26-Oct-20Grant 61,000----59%
102.85K to 163.85K
28-Oct-20 8:36 PM
View: 
Bazemore Todd
Chief Operating Officer
Kala Pharmaceuticals, Inc. (KALA) 26-Oct-20Grant 81,000----279%
29.04K to 110.04K
28-Oct-20 8:32 PM
View: 
Trachtenberg Eric
See Remarks
Kala Pharmaceuticals, Inc. (KALA) 26-Oct-20Grant 61,000----136%
44.9K to 105.9K
28-Oct-20 8:28 PM
View: 
Brazzell Kim
Chief Medical Officer
Kala Pharmaceuticals, Inc. (KALA) 26-Oct-20Grant 81,000----41%
195.5K to 276.5K
28-Oct-20 8:24 PM
View: 
Iwicki Mark T
Chief Executive Officer
Director
Kala Pharmaceuticals, Inc. (KALA) 26-Oct-20Grant 178,300----360%
49.56K to 227.86K
28-Oct-20 8:22 PM
View: 
Reumuth Mary
Chief Financial Officer
Kala Pharmaceuticals, Inc. (KALA) 26-Oct-20Grant 61,000----95%
64.29K to 125.29K
28-Oct-20 8:36 PM
View: 
Bazemore Todd
Chief Operating Officer
Kala Pharmaceuticals, Inc. (KALA) 22-Oct-20Market Purchase 40$7.60$304.00< 1%
29.0K to 29.04K
30-Jun-20 10:00 PM
View: 
Perry Gregory D
Director
Kala Pharmaceuticals, Inc. (KALA) 25-Jun-20Grant 20,000----100%
0 to 20.0K
29-Jun-20 9:58 PM
View: 
Trachtenberg Eric
See Remarks
Kala Pharmaceuticals, Inc. (KALA) 25-Jun-20Grant 16,000----55%
28.9K to 44.9K
29-Jun-20 9:47 PM
View: 
Brazzell Kim
Chief Medical Officer
Kala Pharmaceuticals, Inc. (KALA) 25-Jun-20Grant 19,000----11%
176.5K to 195.5K
30-Jun-20 10:00 PM
View: 
Shah Rajeev M.
Director
10% Owner
Kala Pharmaceuticals, Inc. (KALA) 25-Jun-20Grant 20,000----< 1%
10.87M to 10.89M
29-Jun-20 9:36 PM
View: 
Koven Andrew I
Director
Kala Pharmaceuticals, Inc. (KALA) 25-Jun-20Grant 28,000----100%
0 to 28.0K
30-Jun-20 10:00 PM
View: 
Iwicki Mark T
Chief Executive Officer
Director
Kala Pharmaceuticals, Inc. (KALA) 25-Jun-20Grant 49,560----100%
0 to 49.56K
29-Jun-20 9:48 PM
View: 
Grunberg Gregory
Director
Kala Pharmaceuticals, Inc. (KALA) 25-Jun-20Grant 20,000----< 1%
5.41M to 5.43M
30-Jun-20 10:00 PM
View: 
Reumuth Mary
Chief Financial Officer
Kala Pharmaceuticals, Inc. (KALA) 25-Jun-20Grant 16,000----33%
48.29K to 64.29K
30-Jun-20 10:00 PM
View: 
Rosen Howard B
Director
Kala Pharmaceuticals, Inc. (KALA) 25-Jun-20Grant 20,000----153%
13.06K to 33.06K
30-Jun-20 10:00 PM
View: 
Paull Robert Bradley
Director
Kala Pharmaceuticals, Inc. (KALA) 25-Jun-20Grant 20,000----847%
2.36K to 22.36K
29-Jun-20 9:31 PM
View: 
Chen Hongming
Chief Scientific Officer
Kala Pharmaceuticals, Inc. (KALA) 25-Jun-20Grant 16,000----18%
86.85K to 102.85K